Skip to main content
. 2019 Oct 29;29(9):721–724. doi: 10.1089/cap.2019.0056

Table 2.

Qualitative Analysis of Naltrexone Response

Naltrexone response category Qualitative statement documented in provider note
Really helping; feels it's working “Patient feels naltrexone is really helping and would like to continue.”
Reduced vomiting/urge to vomit “No more vomiting, reduced urges”
“Thinks that the Revia is helping her not think about throwing up”
“Taking naltrexone daily, thinks this is also helping…She would like to stay on the naltrexone as she thinks it is still helping her with urges to vomit.”
“She feels that the Revia is very helpful…has been able to decrease her vomiting of food to only 2 times in the last 2 weeks.”
“She always wants to throw up, not now at every meal as in the past, but constantly has to fight the urge. She thinks that the Revia has been helpful some…She thinks the Revia is still helping her with the urges to vomit, but is still having these urges daily.”
Reduced purging/urge to purge “Thoughts of purging improved with Revia.”
“She continues to purge, but less frequent. Last episodes was ‘weeks' ago, but couldn't remember the exact date. She says she feels ‘awful’ afterward. It no longer gives her the sense of calm.”
“She says that she has only had the urge to purge her intake once since starting naltrexone and feels this has been a good addition.”

Statements above are representative statements reflecting the corresponding naltrexone response category. Revia is a trade name for naltrexone.